Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group-Reference-Cited by-同舟云学术

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

Published:2023-02-22 Issue:7 Volume:40 Page:1601-1631
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Bauer Andrea,Berben Philippe,Chakravarthi Sudhir S.,Chattorraj Sayantan,Garg Ashish,Gourdon Betty,Heimbach Tycho,Huang Ye,Morrison Christopher,Mundhra Deepak,Palaparthy Ramesh,Saha Pratik,Siemons Maxime,Shaik Naveed A.,Shi Yi,Shum Sara,Thakral Naveen K.,Urva Shweta,Vargo Ryan,Koganti Venkat R.,Barrett Stephanie E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-022-03391-y.pdf

Reference137 articles.

1. Li W, Tang J, Lee D, Tice TR, Schwendeman SP, Prausnitz MR. Clinical translation of long-acting drug delivery formulations. Nature Rev Mater. 2022.

2. Shi Y, Lu A, Wang X, Belhadj Z, Wang J, Zhang Q. A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharm Sin B. 2021;11(8):2396–415.

3. Pizzorno A, Padey B, Terrier O, Rosa-Calatrava M. Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy. Front Immunol. 2019;10:531.

4. Selmin F, Musazzi UM, Magri G, Rocco P, Cilurzo F, Minghetti P. Regulatory aspects and quality controls of polymer-based parenteral long-acting drug products: the challenge of approving copies. Drug Discov Today. 2020;25:321–9.

5. Bassand C, Villois A, Gianola L, Laue G, Ramazani F, Riebesehl B, Sanchez-Felix M, Sedo K, Ullrich T, Duvnjak Romic M. Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities. Expert Opin Drug Deliv. 2022:1–19.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Material Trends and Clinical Costings in Systematically Identified CDER‐Approved Nanomedicines;Advanced Therapeutics;2024-09-02

2. Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective;Molecular Pharmaceutics;2024-08-19

3. Biopredictive Dissolutions for Conventional Oral IR, MR and Non-Oral Formulations – Current Status and Future Opportunities;Journal of Drug Delivery Science and Technology;2024-08

4. Exploring the relationship between bulk Young’s Modulus of materials and milling efficiency during wet bead milling of pharmaceutical compounds;International Journal of Pharmaceutics;2024-07

5. Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus Infections;Journal of Medicinal Chemistry;2024-06-27